Midyear Review: 2026 So Far & a Look Forward FDA Watch

Listen on Spotify

Listen on Apple Podcasts

Wayne chats with Paul Kim, Principal of Kendall Square Policy Strategies LLC, and Dr. Susan Mayne, Adjunct Professor at the Yale School of Public Health and former Director of FDA’s Center for Food Safety and Applied Nutrition. Together, they dive into the top FDA developments from the first half of 2026 in several areas, as well as the top developments to watch for in the second half of the year.

This episode and all bonus episodes do not include the usual Headlines and Resources Links segments.

About Our Guests

Dr. Susan Mayne

Susan Mayne, Ph.D., is currently Professor (Adjunct) at the Yale School of Public Health, and from 2015 to 2023 she directed the FDA Center for Food Safety and Applied Nutrition.

Prior to joining the FDA, she spent nearly three decades at the Yale School of Public Health focusing on food and nutrition.

Paul Kim

Paul T. Kim, JD, MPP, is principal of Kendall Square Policy Strategies LLC, providing advice on FDA, life science, and public health policy to Fortune 500 companies, national patient advocates, life science trade associations, and emerging companies in the US, Europe and Korea.

Paul was head of the FDA and federal government strategies practices at a leading law firm for 20 years, following his work as counsel to the late Senator Edward Kennedy, Congressman Henry Waxman, and the late Senator David Pryor. Paul also worked for the FDA, the American Foundation for AIDS Research, and a global biopharmaceutical company.


Discover more from FDA Watch Podcast

Subscribe to get the latest posts sent to your email.